Together we will beat cancer

Donate

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

Read More

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

Read More

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

Read More

ASCO 2019 news: targeted treatment takeover, drugging the ‘undruggable’, obesity and blood tests

The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.

Read More

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

Read More

ASCO 2018 news: ‘blood tests’, breast cancer chemo, kinder treatments and immunotherapy

The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment.

Read More

6 tips to spot cancer ‘fake news’

How can you tell if there’s more to the latest cancer news than meets the eye? Here are a few tips to help you judge a story for yourself.

Read More

News digest – Testosterone, artificial intelligence, genetic tests, the HPV vaccine and… a cuppa?

Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.

Read More

NCRI 2017: How knowing tumours inside and out is boosting progress

In our round-up of this year’s NCRI conference we reveal exciting new research that’s helping scientists get to know cancer better.

Read More

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Read More